Literature DB >> 16949298

Chemotherapy in neoplastic meningitis.

Andrea Pace1, Alessandra Fabi.   

Abstract

Neoplastic meningitis (NM) is the result of the diffuse or multifocal localization of cancer cells in the cerebral spinal fluid (CSF). NM is more often a late complication of solid tumor or lymphoproliferative malignancies. At present, the goal of therapeutic strategies is palliative and the evaluation of high or low risk is important in identifying which patients could benefit from aggressive treatments such as radiation therapy and chemotherapy. Given that NM is a cancer complication that can spread throughout the entire subarachnoid space, chemotherapy, whether intrathecal or systemic, is currently considered the best treatment option, but optimal treatment is still controversial. This review summarizes intrathecal and systemic chemotherapeutic options in the treatment of NM and the related toxicities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949298     DOI: 10.1016/j.critrevonc.2006.06.013

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  7 in total

1.  Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients.

Authors:  Fahed Zairi; Emilie Le Rhun; Nicolas Bertrand; Thomas Boulanger; Sophie Taillibert; Rabih Aboukais; Richard Assaker; Marc C Chamberlain
Journal:  J Neurooncol       Date:  2015-06-13       Impact factor: 4.130

2.  Complications related to the placement of an intraventricular chemotherapy device.

Authors:  Fahed Zairi; Emilie Le Rhun; Marie Charlotte Tetard; Nuria Kotecki; Richard Assaker
Journal:  J Neurooncol       Date:  2010-11-25       Impact factor: 4.130

3.  Leptomeningeal carcinomatosis as the primary presentation of relapse in breast cancer.

Authors:  Keith Sacco; Aun Muhammad; Waqar Saleem; Heba Alshaker; Leonardo Monzon; Mohammad Rafiqul Islam; Dmitri Pchejetski
Journal:  Oncol Lett       Date:  2016-06-16       Impact factor: 2.967

4.  Treatment of spinal cord tumors.

Authors:  Brian Vaillant; Monica Loghin
Journal:  Curr Treat Options Neurol       Date:  2009-07       Impact factor: 3.598

5.  Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.

Authors:  Iole Cordone; Serena Masi; Valentina Summa; Mariantonia Carosi; Antonello Vidiri; Alessandra Fabi; Alessia Pasquale; Laura Conti; Immacolata Rosito; Carmine Maria Carapella; Veronica Villani; Andrea Pace
Journal:  Breast Cancer Res       Date:  2017-04-11       Impact factor: 6.466

6.  A Novel Implantable Cerebrospinal Fluid Reservoir : A Pilot Study.

Authors:  Yoon Hwan Byun; Ho Shin Gwak; Ji-Woong Kwon; Kwang Gi Kim; Sang Hoon Shin; Seung Hoon Lee; Heon Yoo
Journal:  J Korean Neurosurg Soc       Date:  2018-08-31

7.  Incidence and risk factors for leptomeningeal carcinomatosis in breast cancer patients with parenchymal brain metastases.

Authors:  Jong-Myung Jung; Sohee Kim; Jungnam Joo; Kyung Hwan Shin; Ho-Shin Gwak; Seung Hoon Lee
Journal:  J Korean Neurosurg Soc       Date:  2012-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.